SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) MARCH 22, 2005
ICU MEDICAL, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-19974 33-0022692
-------- ------- ----------
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
951 Calle Amanecer, San Clemente, California 92673
-------------------------------------------- ------
(Address of principal executive offices) (Zip Code)
(949) 366-2183
Registrant's telephone number, including area code
N/A
(Former name or former address, if changed since last report)
INFORMATION TO BE INCLUDED IN THE REPORT
Item 1.01 Entry into a Material Definitive Agreement
------------------------------------------
On March 22, 2005, the Company approved amendments to the employment
agreements with Mr. O'Brien, Chief Financial Officer, Mr. Riggs, Vice President
Operations and Ms. Burcar, Vice President Marketing. Mr. O'Brien's base
compensation was increased to $290,000 annually. Bonus provisions for 2005 for
these three individuals were amended to provide for certain new bonuses equal to
approximately 20% annual base compensation for 2005, payable if specific goals
are achieved.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: March 24, 2005
ICU MEDICAL, INC.
/s/ Francis J. O'Brien
----------------------
Francis J. O'Brien
Secretary, Treasurer and
Chief Financial Officer